Next Generation Immunology Drugs Global and China Top Players Market

Next-Generation Immunology Drugs - Global and China Top Players Market Share and Ranking 2023

Next Generation Immunology Drugs Global and China Top Players Market

Next-Generation Immunology Drugs - Global and China Top Players Market Share and Ranking 2023

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Research, the global market for Next-Generation Immunology Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Next-Generation Immunology Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Next-Generation Immunology Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.

This report studies and analyses global Next-Generation Immunology Drugs status and future trends, to help determine the Next-Generation Immunology Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Next-Generation Immunology Drugs, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Next-Generation Immunology Drugs market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)

(2) Global Next-Generation Immunology Drugs by company, revenue, market share and industry ranking 2018-2023, (US$ million)

(3) China Next-Generation Immunology Drugs by company, revenue, market share and industry ranking 2018-2023, (US$ million)

(4) Global Next-Generation Immunology Drugs key consuming regions, consumption value and demand structure

(5) Next-Generation Immunology Drugs industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Pfizer Inc

Abbvie Inc.

Johnson and Johnson

F. Hoffmann-La Roche Ltd.

Amgen Inc.

Novartis AG

Astellas Pharma Inc.

Bristol-Myers Squibb Company

Merck & Co., Inc.

Eli Lilly and Company

Market segment by Type, covers

Cell Therapy

Small Molecule Drug

Others

Market segment by Application, can be divided into

Hospital

Clinic

Others

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Next-Generation Immunology Drugs product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.

Chapter 2: Global Next-Generation Immunology Drugs market share and ranking of major manufacturers, revenue, 2018-2023

Chapter 3: China Next-Generation Immunology Drugs market share and ranking of major manufacturers, revenue, 2018-2023

Chapter 4: Next-Generation Immunology Drugs industry chain, upstream, medium-stream, and downstream.

Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029

Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029

Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.

Chapter 10: Conclusions

1 Market Overview

1.1 Next-Generation Immunology Drugs Definition

1.2 Global Next-Generation Immunology Drugs Market Size and Forecast

1.3 China Next-Generation Immunology Drugs Market Size and Forecast

1.4 China Percentage in Global Market

1.5 Next-Generation Immunology Drugs Market Size: China VS Global Growth Rate, 2018-2029

1.6 Next-Generation Immunology Drugs Market Dynamics

1.6.1 Next-Generation Immunology Drugs Market Drivers

1.6.2 Next-Generation Immunology Drugs Market Restraints

1.6.3 Next-Generation Immunology Drugs Industry Trends

1.6.4 Next-Generation Immunology Drugs Industry Policy

2 Global Leading Players and Market Share

2.1 By Revenue of Next-Generation Immunology Drugs, Global Market Share by Company, 2018-2023

2.2 Global Next-Generation Immunology Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Next-Generation Immunology Drugs Concentration Ratio

2.4 Global Next-Generation Immunology Drugs Mergers & Acquisitions, Expansion Plans

2.5 Global Next-Generation Immunology Drugs Major Companies Product Type

2.6 Head Office and Next-Generation Immunology Drugs Production Site of Key Manufacturer

3 China Leading Players, Market Share and Ranking

3.1 By Revenue of Next-Generation Immunology Drugs, China Market Share by Company, 2018-2023

3.2 China Next-Generation Immunology Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis

4.1 Next-Generation Immunology Drugs Industry Chain

4.2 Next-Generation Immunology Drugs Upstream Analysis

4.2.1 Next-Generation Immunology Drugs Core Raw Materials

4.2.2 Main Manufacturers of Next-Generation Immunology Drugs Core Raw Materials

4.3 Midstream Analysis

4.4 Downstream Analysis

4.5 Next-Generation Immunology Drugs Production Mode

4.6 Next-Generation Immunology Drugs Procurement Model

4.7 Next-Generation Immunology Drugs Industry Sales Model and Sales Channels

4.7.1 Next-Generation Immunology Drugs Sales Model

4.7.2 Next-Generation Immunology Drugs Typical Distributors

5 Sights by Type

5.1 Next-Generation Immunology Drugs Classification

5.1.1 Cell Therapy

5.1.2 Small Molecule Drug

5.1.3 Others

5.2 By Type, Global Next-Generation Immunology Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Next-Generation Immunology Drugs Consumption Value, 2018-2029

6 Sights by Application

6.1 Next-Generation Immunology Drugs Segment by Application

6.1.1 Hospital

6.1.2 Clinic

6.1.3 Others

6.2 By Application, Global Next-Generation Immunology Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Next-Generation Immunology Drugs Consumption Value, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Next-Generation Immunology Drugs Consumption Value, 2018 VS 2022 VS 2029

7.2 By Region, Global Next-Generation Immunology Drugs Consumption Value, 2018-2029

7.3 North America

7.3.1 North America Next-Generation Immunology Drugs & Forecasts, 2018-2029

7.3.2 By Country, North America Next-Generation Immunology Drugs Market Size Market Share

7.4 Europe

7.4.1 Europe Next-Generation Immunology Drugs Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Next-Generation Immunology Drugs Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Next-Generation Immunology Drugs Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Next-Generation Immunology Drugs Market Size Market Share

7.6 South America

7.6.1 South America Next-Generation Immunology Drugs Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Next-Generation Immunology Drugs Market Size Market Share

7.7 Middle East & Africa

8 Sales Sights by Country Level

8.1 By Country, Global Next-Generation Immunology Drugs Market Size & CAGR, 2018 VS 2022 VS 2029

8.2 By Country, Global Next-Generation Immunology Drugs Consumption Value, 2018-2029

8.3 U.S.

8.3.1 U.S. Next-Generation Immunology Drugs Market Size, 2018-2029

8.3.2 By Type, U.S. Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.3.3 By Application, U.S. Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Next-Generation Immunology Drugs Market Size, 2018-2029

8.4.2 By Type, Europe Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.4.3 By Application, Europe Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.5 China

8.5.1 China Next-Generation Immunology Drugs Market Size, 2018-2029

8.5.2 By Type, China Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.5.3 By Application, China Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Next-Generation Immunology Drugs Market Size, 2018-2029

8.6.2 By Type, Japan Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.6.3 By Application, Japan Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Next-Generation Immunology Drugs Market Size, 2018-2029

8.7.2 By Type, South Korea Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.7.3 By Application, South Korea Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Next-Generation Immunology Drugs Market Size, 2018-2029

8.8.2 By Type, Southeast Asia Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.8.3 By Application, Southeast Asia Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.9 India

8.9.1 India Next-Generation Immunology Drugs Market Size, 2018-2029

8.9.2 By Type, India Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.9.3 By Application, India Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.10 Middle East & Africa

8.10.1 Middle East & Africa Next-Generation Immunology Drugs Market Size, 2018-2029

8.10.2 By Type, Middle East & Africa Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

8.10.3 By Application, Middle East & Africa Next-Generation Immunology Drugs Consumption Value Market Share, 2022 VS 2029

9 Company Profile

9.1 Pfizer Inc

9.1.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position

9.1.2 Pfizer Inc Company Profile and Main Business

9.1.3 Pfizer Inc Next-Generation Immunology Drugs Models, Specifications and Application

9.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.1.5 Pfizer Inc Recent Developments

9.2 Abbvie Inc.

9.2.1 Abbvie Inc. Company Information, Head Office, Market Area and Industry Position

9.2.2 Abbvie Inc. Company Profile and Main Business

9.2.3 Abbvie Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.2.5 Abbvie Inc. Recent Developments

9.3 Johnson and Johnson

9.3.1 Johnson and Johnson Company Information, Head Office, Market Area and Industry Position

9.3.2 Johnson and Johnson Company Profile and Main Business

9.3.3 Johnson and Johnson Next-Generation Immunology Drugs Models, Specifications and Application

9.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.3.5 Johnson and Johnson Recent Developments

9.4 F. Hoffmann-La Roche Ltd.

9.4.1 F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position

9.4.2 F. Hoffmann-La Roche Ltd. Company Profile and Main Business

9.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Models, Specifications and Application

9.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.4.5 F. Hoffmann-La Roche Ltd. Recent Developments

9.5 Amgen Inc.

9.5.1 Amgen Inc. Company Information, Head Office, Market Area and Industry Position

9.5.2 Amgen Inc. Company Profile and Main Business

9.5.3 Amgen Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.5.5 Amgen Inc. Recent Developments

9.6 Novartis AG

9.6.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.6.2 Novartis AG Company Profile and Main Business

9.6.3 Novartis AG Next-Generation Immunology Drugs Models, Specifications and Application

9.6.4 Novartis AG Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.6.5 Novartis AG Recent Developments

9.7 Astellas Pharma Inc.

9.7.1 Astellas Pharma Inc. Company Information, Head Office, Market Area and Industry Position

9.7.2 Astellas Pharma Inc. Company Profile and Main Business

9.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.7.5 Astellas Pharma Inc. Recent Developments

9.8 Bristol-Myers Squibb Company

9.8.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

9.8.2 Bristol-Myers Squibb Company Company Profile and Main Business

9.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Models, Specifications and Application

9.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.8.5 Bristol-Myers Squibb Company Recent Developments

9.9 Merck & Co., Inc.

9.9.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position

9.9.2 Merck & Co., Inc. Company Profile and Main Business

9.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.9.5 Merck & Co., Inc. Recent Developments

9.10 Eli Lilly and Company

9.10.1 Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position

9.10.2 Eli Lilly and Company Company Profile and Main Business

9.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Models, Specifications and Application

9.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.10.5 Eli Lilly and Company Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Next Generation Immunology Drugs Global and China Top Players Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why are some of the most well-known companies left out of the Next Generation Immunology Drugs Global and China Top Players Market study?
The Next Generation Immunology Drugs Global and China Top Players study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
What is the forecasted growth rate of the Next Generation Immunology Drugs Global and China Top Players Market?
The Next Generation Immunology Drugs Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
Where does the Next Generation Immunology Drugs Global and China Top Players Industry stands in terms of scaling end-use implementations?
According to the Next Generation Immunology Drugs Global and China Top Players Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
How is the competitive landscape for the Next Generation Immunology Drugs Global and China Top Players Market defined?
Companies in the Next Generation Immunology Drugs Global and China Top Players Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Next Generation Immunology Drugs Global and China Top Players Market's trajectory and future outlook.